₹ 2,708.85
-23.75 (-0.87%)Open
2774.5High
2774.5Low
2700.2Prev Close
2732.6P/E
61.53Median P/E
31.46P/B
14.93Median P/B
4.53Market Cap
920.52BPEG
1.67Div.Yield
1.1Bid
2,707.00Ask
2,709.80Large Cap
920.52B Mkt. Cap.Volatility
-Beta
0.43Genie Says
Influencer Count
-Days | BSE | NSE |
---|
5 | 2,684.00 | 2,684.23 |
10 | 2,615.11 | 2,615.68 |
20 | 2,606.99 | 2,606.83 |
50 | 2,614.74 | 2,615.04 |
100 | 2,480.04 | 2,480.41 |
300 | 2,216.47 | 2,216.79 |
BSE
500420NSE
TORNTPHARMISIN
INE685A01028Torrent Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is focused on various therapeutic segments, such as cardiovascular (CV), central nervous system (CNS), gastrointestinal (GI), vitamins minerals nutrients (VMN), anti-diabetes (AD), pain, gynecology, and dermatology. The Company is engaged in research, development, manufacturing, marketing and distribution of branded and generic pharmaceutical formulations in India and internationally. Its pediatric product brands include Tedibar, Atogla, Spoo and B4 Nappi. Its acne/facecare products brands include Clinmiskin, ACNEMOIST, TRACNILO and fash. The Company's hair/scalp care products brands include Proanagen, Perlice, Permite and NOSKURF. Its manufacturing facilities are located in the states of Gujarat, Himachal Pradesh, Madhya Pradesh, Andhra Pradesh and Sikkim. The Company's primary channel of distribution is through the wholesale drug distributors, stockiest and retail pharmacies.
Samir Mehta
Executive Chairman of the BoardSudhir Menon
Chief Financial Officer, Executive Director - FinanceChintan Trivedi
Compliance Officer, Company SecretaryAman Mehta
Executive DirectorJinesh Shah
Whole-Time Director, Director - Operations